• Aug 26, 2026

  $262.90-1.09%

  Comparable listed companies in Pharmaceutical Preparations fell -1.76% on average, with all six peers declining [1]. ABBV's -1.09% decline came alongside this broad sector weakness.

  • 1Peer group

• Aug 25, 2026

  $265.79+0.48%

  Comparable listed companies in Pharmaceutical Preparations rose +0.91% on average, with four of six peers gaining [1]. ABBV's modest +0.48% gain came alongside this sector-wide move.

  • 1Peer group

• Aug 24, 2026

  $264.52-0.17%

• Aug 21, 2026

  $264.96+1.20%

  Comparable listed companies in Pharmaceutical Preparations rose +1.50% on average, with all six peers gaining [1]. ABBV's +1.20% advance came alongside this broad sector strength.

  • 1Peer group

• Aug 20, 2026

  $261.83-1.56%

  Comparable listed companies in Pharmaceutical Preparations fell -1.85% on average, with all six peers declining [1]. ABBV's -1.56% decline came alongside this broad sector weakness.

  • 1Peer group

• Aug 19, 2026

  $265.97+2.72%

  Comparable listed companies in Pharmaceutical Preparations rose +4.60% on average, with all six peers gaining [1]. ABBV's +2.72% advance came alongside this broad sector move, though it lagged the peer average.

  • 1Peer group

• Aug 18, 2026

  $258.92+3.43%

  Comparable listed companies in Pharmaceutical Preparations rose +2.05% on average, with five of six peers gaining [1]. ABBV's +3.43% advance came alongside this broad sector strength.

  • 1Peer group

Closing prices for ABBV. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.